|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,450.00 KRW | -6.71% |
|
-8.44% | -34.75% |
| Dec. 09 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 25-06-12 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -6.71% | -8.44% | -16.51% | -40.51% | -34.75% | -51.74% | - | - | - | 70.48M | |
| +1.09% | -3.84% | +28.68% | +35.16% | +19.12% | +70.10% | +437.29% | +134.24% | +2,146.01% | 39.08B | |
| -0.05% | -2.71% | +3.95% | +4.73% | +10.28% | +10.84% | +30.67% | -1.08% | +103.59% | 22.69B | |
| +2.22% | -2.10% | +7.32% | +6.52% | -5.35% | -21.47% | -40.07% | -44.90% | -2.28% | 7.17B | |
| -3.49% | -8.14% | +11.64% | +12.59% | -11.27% | +14.11% | +106.96% | +85.55% | +1,020.53% | 4.98B | |
| +0.56% | +3.13% | +7.26% | +20.57% | +16.92% | +19.65% | +47.11% | +0.13% | +255.22% | 3.01B | |
| -2.73% | -7.32% | +6.56% | +4.71% | -50.91% | -22.66% | +818.71% | -84.27% | - | 1.9B | |
| -1.17% | +4.12% | +2.17% | +9.42% | +27.57% | +33.47% | -21.11% | -41.41% | -40.14% | 1.82B | |
| 0.00% | -6.93% | +26.55% | +76.38% | +19.98% | +94.35% | -18.81% | -68.78% | +50.75% | 1.84B | |
| +4.87% | +3.19% | +6.39% | -6.43% | +7.67% | +27.97% | +4.06% | -32.14% | +12.52% | 1.71B | |
| +4.87% | +8.62% | +2.14% | -2.09% | -8.96% | -8.86% | -66.49% | -80.62% | - | 1.76B | |
| -0.90% | +2.70% | +7.19% | +35.48% | +29.64% | +34.79% | +198.57% | - | - | 1.49B | |
| -0.57% | -1.54% | +6.41% | +22.14% | +17.10% | +19.81% | +58.42% | -19.61% | - | 1.22B | |
| +0.87% | -2.82% | +3.95% | +7.63% | -0.30% | +5.87% | +23.02% | +18.03% | -29.75% | 1.13B | |
| -8.89% | -18.00% | -13.38% | +5.13% | -2.38% | -8.89% | -41.15% | -66.39% | -87.20% | 929M | |
| +3.80% | -0.14% | -0.86% | +33.25% | +19.07% | +37.26% | +192.43% | +18.70% | +193.67% | 849M | |
| +0.83% | +0.27% | +1.10% | -7.80% | -5.05% | +8.43% | +28.46% | -4.93% | +46.89% | 839M | |
| -2.36% | -4.61% | +4.06% | -10.66% | -3.46% | -13.73% | -48.41% | -69.23% | - | 766M | |
| +0.88% | -4.68% | +21.02% | +47.67% | +21.02% | +516.22% | +2,378.26% | - | - | 626M | |
| +2.99% | -4.72% | +26.20% | -10.32% | -0.69% | +41.13% | +8.38% | - | - | 602M | |
| Average | -0.19% | -1.88% | +7.09% | +12.18% | +3.26% | +40.33% | +215.59% | -16.04% | +305.82% | 4.72B | |
| Weighted average by Cap. | +0.49% | -2.86% | +15.50% | +20.45% | +10.66% | +38.43% | +228.14% | +50.82% | +1,071.20% |
- Stock Market
- Stocks
- A340450 Stock
- Sector GC Genome Corporation
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
